+19.8%
DDOG vs MRNA
+945.0%
-925.2%
-48.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -14.4% | +13.1% | -27.5% | -14.4% |
| 7D | -32.2% | +20.6% | -52.9% | -32.2% |
| 30D | -31.7% | +27.1% | -58.9% | -31.6% |
| 3M | -34.5% | +353.4% | -387.9% | -34.4% |
| 6M | +28.7% | +446.3% | -417.6% | +24.1% |
| YTD | +38.8% | +776.2% | -737.4% | +17.5% |
| 1Y | +19.8% | +987.9% | -968.1% | -10.3% |
| All | +19.8% | +945.0% | -925.2% | -10.3% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling